19970-1-AP

antibody from Proteintech Group

Targeting: MAP3K1 MAPKKK1, MEKK, MEKK1

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

19970-1-AP

Provider

Proteintech Group

Product name

MAP3K1 antibody

Antibody type

Polyclonal

Description

KD/KO validated MAP3K1 antibody (Cat. #19970-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, WB,ELISA.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1.

Li Z, Wang R, Wang D, Zhang S, Song H, Ding S, Zhu Y, Wen X, Li H, Chen H, Liu S, Sun L
Journal of immunology research 2023;2023:6696967

---

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

Yuan J, Lv T, Yang J, Wu Z, Yan L, Yang J, Shi Y, Jiang L
Cellular and molecular gastroenterology and hepatology 2023;15(2):307-325

---

Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.

Bao JH, Lu WC, Duan H, Ye YQ, Li JB, Liao WT, Li YC, Sun YP
Frontiers in immunology 2022;13:933973

---

The MAP3K1/c-JUN signaling axis regulates glioblastoma stem cell invasion and tumor progression.

Zhou S, Niu R, Sun H, Kim SH, Jin X, Yin J
Biochemical and biophysical research communications 2022 Jul 5;612:188-195

---

Extracellular vesicles secreted from mesenchymal stem cells exert anti-apoptotic and anti-inflammatory effects via transmitting microRNA-18b in rats with diabetic retinopathy.

Xu Z, Tian N, Li S, Li K, Guo H, Zhang H, Jin H, An M, Yu X
International immunopharmacology 2021 Dec;101(Pt B):108234

---

LncRNA KCNQ1OT1 activated by c-Myc promotes cell proliferation via interacting with FUS to stabilize MAP3K1 in acute promyelocytic leukemia.

Tang D, Luo Y, Jiang Y, Hu P, Peng H, Wu S, Zhang G, Wang Y
Cell death & disease 2021 Aug 17;12(9):795

---

LncRNA SLCO4A1-AS1 predicts poor prognosis and promotes proliferation and metastasis via the EGFR/MAPK pathway in colorectal cancer.

Tang R, Chen J, Tang M, Liao Z, Zhou L, Jiang J, Hu Y, Liao Q, Xiong W, Tang Y, Nie S
International journal of biological sciences 2019;15(13):2885-2896

---

USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling.

Zhou J, Qiu T, Wang T, Chen Z, Ma X, Zhang L, Zou J
Clinical science (London, England : 1979) 2019 Jan 31;133(2):335-349

---

MicroRNAs profiling in fibroblasts derived from patients with Gorlin syndrome.

Shiohama T, Fujii K, Miyashita T, Takatani T, Ikehara H, Uchikawa H, Motojima T, Uchida T, Shimojo N
Journal of human genetics 2019 Aug;64(8):757-765

---

Xihuang pill promotes apoptosis of Treg cells in the tumor microenvironment in 4T1 mouse breast cancer by upregulating MEKK1/SEK1/JNK1/AP-1 pathway.

Su L, Jiang Y, Xu Y, Li X, Gao W, Xu C, Zeng C, Song J, Weng W, Liang W
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018 Jun;102:1111-1119